Extracorporeal membrane oxygenation in adult patients with sepsis and septic shock: Why, how, when, and for whom

Hongling Zhang , Youdong Xu , Xin Huang , Shunyin Yang , Ruiting Li , Yongran Wu , Xiaojing Zou , Yuan Yu , You Shang
{"title":"Extracorporeal membrane oxygenation in adult patients with sepsis and septic shock: Why, how, when, and for whom","authors":"Hongling Zhang ,&nbsp;Youdong Xu ,&nbsp;Xin Huang ,&nbsp;Shunyin Yang ,&nbsp;Ruiting Li ,&nbsp;Yongran Wu ,&nbsp;Xiaojing Zou ,&nbsp;Yuan Yu ,&nbsp;You Shang","doi":"10.1016/j.jointm.2023.07.001","DOIUrl":null,"url":null,"abstract":"<div><p>Sepsis and septic shock remain the leading causes of death in intensive care units. Some patients with sepsis fail to respond to routine treatment and rapidly progress to refractory respiratory and circulatory failure, necessitating extracorporeal membrane oxygenation (ECMO). However, the role of ECMO in adult patients with sepsis has not been fully established. According to existing studies, ECMO may be a viable salvage therapy in carefully selected adult patients with sepsis. The choice of venovenous, venoarterial, or hybrid ECMO modes is primarily determined by the patient's oxygenation and hemodynamics (distributive shock with preserved cardiac output, septic cardiomyopathy (left, right, or biventricular heart failure), or right ventricular failure caused by acute respiratory distress syndrome). Veno-venous ECMO can be used in patients with sepsis and severe acute respiratory distress syndrome when conventional mechanical ventilation fails, and early application of veno-arterial ECMO in patients with sepsis-induced refractory cardiogenic shock may be critical in improving their chances of survival. When ECMO is indicated, the choice of an appropriate mode and determination of the optimal timing of initiation and weaning are critical, particularly in an experienced ECMO center. Furthermore, some special issues, such as ECMO flow, anticoagulation, and antibiotic therapy, should be noted during the management of ECMO support.</p></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667100X23000488/pdfft?md5=62ca2f57cb6c1f160dbd7674e91a4148&pid=1-s2.0-S2667100X23000488-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of intensive medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667100X23000488","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Sepsis and septic shock remain the leading causes of death in intensive care units. Some patients with sepsis fail to respond to routine treatment and rapidly progress to refractory respiratory and circulatory failure, necessitating extracorporeal membrane oxygenation (ECMO). However, the role of ECMO in adult patients with sepsis has not been fully established. According to existing studies, ECMO may be a viable salvage therapy in carefully selected adult patients with sepsis. The choice of venovenous, venoarterial, or hybrid ECMO modes is primarily determined by the patient's oxygenation and hemodynamics (distributive shock with preserved cardiac output, septic cardiomyopathy (left, right, or biventricular heart failure), or right ventricular failure caused by acute respiratory distress syndrome). Veno-venous ECMO can be used in patients with sepsis and severe acute respiratory distress syndrome when conventional mechanical ventilation fails, and early application of veno-arterial ECMO in patients with sepsis-induced refractory cardiogenic shock may be critical in improving their chances of survival. When ECMO is indicated, the choice of an appropriate mode and determination of the optimal timing of initiation and weaning are critical, particularly in an experienced ECMO center. Furthermore, some special issues, such as ECMO flow, anticoagulation, and antibiotic therapy, should be noted during the management of ECMO support.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脓毒症和脓毒性休克成人患者的体外膜肺氧合:为什么、如何、何时以及为谁进行治疗
败血症和脓毒性休克仍然是重症监护病房的主要死因。一些脓毒症患者对常规治疗无效,并迅速发展为难治性呼吸和循环衰竭,需要进行体外膜肺氧合(ECMO)治疗。然而,ECMO 在成年脓毒症患者中的作用尚未完全确定。根据现有研究,ECMO 可能是精心挑选的成年脓毒症患者的一种可行的挽救疗法。静脉、静脉动脉或混合 ECMO 模式的选择主要取决于患者的氧合和血流动力学情况(心输出量保留的分布性休克、脓毒症心肌病(左、右或双心室心衰)或急性呼吸窘迫综合征引起的右心室衰竭)。当常规机械通气失败时,静脉-静脉 ECMO 可用于脓毒症和严重急性呼吸窘迫综合征患者,而对于脓毒症引起的难治性心源性休克患者,早期应用静脉-动脉 ECMO 可能是提高其存活机会的关键。当需要使用 ECMO 时,选择合适的模式以及确定最佳的启动和断流时间至关重要,尤其是在经验丰富的 ECMO 中心。此外,在管理 ECMO 支持过程中还应注意一些特殊问题,如 ECMO 流量、抗凝和抗生素治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of intensive medicine
Journal of intensive medicine Critical Care and Intensive Care Medicine
CiteScore
1.90
自引率
0.00%
发文量
0
审稿时长
58 days
期刊最新文献
Advancing understanding and management of invasive fungal diseases in the intensive care unit: Insights from FUNDICU consensus definitions Investigating computational models for diagnosis and prognosis of sepsis based on clinical parameters: Opportunities, challenges, and future research directions Association between hyperglycemia at ICU admission and postoperative acute kidney injury in patients undergoing cardiac surgery: Analysis of the MIMIC-IV database Adaptive platform trials in critical care Metabolomic profiling and prognostication in COVID-19 acute respiratory distress syndrome
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1